This life sciences stock has a secret weapon, and AI will only make it more valuable
IQVIA, with its vast trove of health information, sits at the center of drug development, providing data, tools and services to conduct research and perform clinical trials. After a supply chain destocking cycle, growth and backlog are improving and have allowed the company to raise its guidance. IQVIA recently launched an AI platform in partnership…